SCHEMBL9566626

SCHEMBL9566626

Nc1nc(N=O)nc(-c2cc(Br)ccc2Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.50
PDE4D Q08499 1/20 0.50
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
HIF1A Q16665 1/20 0.39
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
AGPAT2 O15120 4/20 0.36
HSP90AA1 P07900 4/20 0.35
TRAP1 Q12931 3/20 0.33
HSP90B1 P14625 2/20 0.33
HSP90AB1 P08238 2/20 0.32
HRH4 Q9H3N8 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9566467 0.85 HTR2B (0.71) HTR2BPDE4DSMN1; SMN2NPC1RAB9A
SCHEMBL9566593 0.85 HTR2B (0.68) HTR2BPDE4DMAPTXBP1HIF1A
SCHEMBL4369095 0.70 AGPAT2 (0.68) HTR2BPDE4DMAPTSMN1; SMN2NPC1
SCHEMBL2622394 0.69 AGPAT2 (0.65) HTR2BPDE4DMAPTHTTSMN1; SMN2
SCHEMBL4292357 0.68 HSP90AA1 (0.63) HTR2BPDE4DMAPTXBP1HIF1A
SCHEMBL6049548 0.68 DHFR (0.47) HTR2BPDE4DMAPTXBP1HIF1A
SCHEMBL9566542 0.68 HTR2B (0.72) HTR2BPDE4DMAPTXBP1HIF1A
Irsogladine SCHEMBL29517870 0.68 HTR2B (1.00) HTR2BPDE4DSMN1; SMN2NPC1RAB9A
Irsogladine SCHEMBL62215 0.68 HTR2B (1.00) HTR2BPDE4DSMN1; SMN2NPC1RAB9A
SCHEMBL9566518 0.68 NPC1 (0.47) HTR2BPDE4DMAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563386-A1 ANTICANCER COMPOSITION AND COMPOUND NIPPON SHINYAKU COMPANY, LIMITED (JP) 1993-10-06 EP disclosed